Sumitomo Pharma Co., Ltd. (TYO:4506)
Japan · Delayed Price · Currency is JPY 1,501.00
-28.00 (-1.83%)
Jun 30, 2026, 3:30 PM JST
Sumitomo Pharma Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Sumitomo Pharma stock has a consensus rating of "Hold" and an average price target of ¥2,129. The average 1-year stock price forecast is 41.81% higher than the current stock price, while the lowest is ¥1,500 (-0.07%) and the highest is ¥2,700 (+79.88%).
Price Target: ¥2,129 (+41.81%)
Analyst Consensus: Hold
* Price targets were last updated on May 26, 2026.
Analyst Ratings
The average analyst rating for Sumitomo Pharma stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 3 | 3 | 2 | 2 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 7 | 7 | 6 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Sell Maintains ¥1,500 | Sell | Maintains | ¥1,500 | -0.07% | May 26, 2026 |
Financial Forecast
Revenue This Year
549.77B
from 453.29B
Increased by 21.28%
Revenue Next Year
602.62B
from 549.77B
Increased by 9.61%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is JPY.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 568.6B | ||
| Avg | 549.8B | ||
| Low | 540.4B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 25.4% | ||
| Avg | 21.3% | ||
| Low | 19.2% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |
EPS Growth
| EPS Growth | 2028 | 2029 |
|---|---|---|
| High | - | |
| Avg | - | |
| Low | - |